Molecular mousetraps, α1-antitrypsin deficiency and the serpinopathies

Author： Lomas David A  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.5, Iss.3, 2005-05, pp. : 249-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flu vax not effective in α1-antitrypsin deficiency

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 547, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Augmentation Therapy for 1 -Antitrypsin Deficiency

By Georges S. Juvelekian   James K. Stoller  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1743-1756

Adis International

Access to resources Recommend Favorite

Treatment of 1-antitrypsin deficiency is costly

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 309, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Treatment of 1-antitrypsin deficiency is costly

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

α 1 -Proteinase Inhibitor (Human) in the Treatment of Hereditary Emphysema Secondary to α 1 -Antitrypsin Deficiency: Number and Costs of Years of Life Gained

By >   Evans Marc A.   Robison Linda M.   Skaer Tracy L.  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 353-360

Adis International

Access to resources Recommend Favorite